Kiniksa Pharmaceuticals International, plc (KNSA) Technical Analysis & Indicators

Kiniksa Pharmaceuticals International, plc (KNSA) — Price $93.29 (closing price, November 3, 2026) — Healthcare — Medical - Pharmaceuticals — NASDAQ

Latest reported results:

Technical analysis of Kiniksa Pharmaceuticals International, plc (KNSA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis.

Price Performance

1 month+18.99%
3 months+18.68%
Year-to-date+120.12%
1 year+135.60%
3 years+460.49%
5 years+516.43%

52-Week Range

52-week High$98.48
52-week Low$36.56
Avg Volume (90d)740K

Technical Indicators

SMA 50$79.39
SMA 200$60.47
Beta0.06
30-day Volatility (annualised)70.7%
Price vs SMA 50+14.4%
Price vs SMA 200+50.2%

Monthly Close (12 months)

MonthCloseChange
2025-12$41.25
2026-01$43.92+6.5%
2026-02$44.49+1.3%
2026-03$48.15+8.2%
2026-04$53.78+11.7%
2026-05$48.38-10.0%
2026-06$63.95+32.2%
2026-07$74.34+16.2%
2026-08$78.63+5.8%
2026-09$74.61-5.1%
2026-10$92.24+23.6%
2026-11$90.80-1.6%

Upcoming Earnings

DateEPS Est.Revenue Est.
2027-02-23$0.25$303M
2026-10-27$0.37$261M
2026-07-28$0.30$226M
2026-04-28$0.18$206M
2026-02-24$0.29$201M
2025-10-28$0.33$197M
2025-07-29$0.18$166M

Price

Price$93.29 (closing price, November 3, 2026)
Market Cap$7.3B
ExchangeNASDAQ
CountryGB

Valuation Ratios

P/E Ratio71.21
Price / Book10.27
Dividend Yield0.00%

Financial Health

Debt / Equity0.01
Current Ratio3.91
Piotroski F-Score5
Altman Z-Score10.35

Related companies: IMVT · DNTH · SYRE · ORKA · NRIX

Explore sector: Healthcare · Medical - Pharmaceuticals

More sections of KNSA: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks